A relatively new treatment, Neonatal therapeutic hypothermia is a procedure wherein an infant’s body temperature is lowered shortly after birth with hopes to reduce the chances of permanent brain damage and cut down disease progression. With additional studies and research going on, medical experts are advocates already understand & feel the benefits greatly outweigh any risks.
With previous research indicating that injured people have healed easier while cold or in extremely cold weather. Based on these studies and research, scientists developed the idea to place injured new-borns in a clinical setting which lowers their body temperatures. As brain cells deteriorate within minutes of losing oxygen, treatment must begin immediately.
Neonatal hypoxic-ischemic encephalopathy (HIE) takes place in around 1 to 6 out of every 1,000 births. without immediate treatment, infants are at risk of serious brain damage, but fatalities as well. Many infants with HIE are subject to neonatal therapeutic hypothermia, during which, they are placed in a clinical setting through which the temperature is around 33 °C., and generally lasts around three days.
With the type of clinical setting depending upon the infant’s injuries, in most instances, babies are put on a cooling blanket filled with water. Where they are monitored for several days as their metabolic processes slow down.